Stock futures higher, but crude oil weakens
By Ryan Vlastelica
NEW YORK (Reuters) - U.S. stock index futures rose on Monday, pointing to a second straight daily gain as a trio of M&A deals lifted sentiment after a recent bout of weakness.
* Despite that, energy shares could come under pressure as crude oil fell sharply, due to a possible deal with Iran that could bring an end to sanctions and allow an increase in the country's oil exports. Crude oil fell 1.8 percent to $47.94 per barrel.
* Separately, an increase in the U.S. dollar could weigh on multi-nationals.
* Both the dollar and commodity prices have given investors reason to be cautious of late, especially going into the first-quarter earnings season, where traders will look to see how much oil prices and the strong U.S. dollar will impact corporate bottom lines. Last week, the S&P 500 fell 2.2 percent, the Dow lost 2.3 percent and the Nasdaq declined 2.7 percent.
* In deal news, OptumRx Corp, a unit of UnitedHealth Group, agreed to buy pharmacy benefit manager Catamaran Corp in a deal worth $12.78 billion. Shares of UnitedHealth, a Dow component, rose 2.7 percent to $121.60 before the bell while U.S. shares of Catamaran added 26 percent to $60.75.
* Ireland's Horizon Pharma Plc said it would acquire Hyperion Therapeutics Inc in an all-cash deal worth about $1.1 billion, while Fujifilm Holdings Corp agreed to acquire U.S. biotechnology firm Cellular Dynamics International Inc for $307 million. [ID:nL3N0WW3JC][ID:nT9N0W802R]
* Hyperion rose 5.6 percent to $45.13 in light premarket trading while Cellular more than doubled in premarket and was among the most active Nasdaq stocks.
* The deals follow reports last week of Intel Corp being in talks to buy Altera Corp in a deal that could top $10 billion. [ID:nL3N0WT59X] Continued...